Selective abdominal venous congestion induces adverse renal and hepatic morphological and functional alterations despite a preserved cardiac function by Cops, Jirka et al.
1SCIENtIFIC RePoRtS |         (2018) 8:17757  | DOI:10.1038/s41598-018-36189-3
www.nature.com/scientificreports
Selective abdominal venous 
congestion induces adverse renal 
and hepatic morphological and 
functional alterations despite a 
preserved cardiac function
Jirka Cops  1,2, Wilfried Mullens1,3, Frederik H. Verbrugge3, Quirine Swennen1, Bart De 
Moor  1,4, Carmen Reynders5, Joris Penders  1,5, Ruth Achten1,6, Ann Driessen7, 
Amélie Dendooven7, Jean-Michel Rigo1 & Dominique Hansen1,8,9
Venous congestion is an important contributor to worsening renal function in heart failure and the 
cardiorenal syndrome. In patients, it is difficult to study the effects of isolated venous congestion 
on organ function. In this study, the consequences of isolated abdominal venous congestion on 
morphology and function of the kidneys, liver and heart were studied in a rat model. Twelve sham-
operated (SHAM) male Sprague Dawley rats were compared to eleven inferior vena cava-constricted 
(IVCc) rats for twenty-one weeks. Abdominal venous pressure was significantly higher in the IVCc versus 
SHAM group (p < 0.0001). Indices of liver and kidney weight, function and morphology, inflammation 
as well as collagen deposition were significantly increased in the IVCc compared to SHAM group, 
(p < 0.05). Echocardiographic and hemodynamic parameters were largely unaffected by abdominal 
venous congestion. In this rat model of isolated abdominal venous congestion, retrogradely conducted 
glomerular hypertension without a concomitant change in glomerular filtration rate was observed. 
Adverse short-term hepatic morphological alterations were developed which explain the observed 
organ function dysfunction. Importantly, cardiac function remained comparable between both groups. 
This study provides relevant insight in the pathophysiology of abdominal congestion on organ function.
Heart failure is defined as a condition whereby the heart is not able to maintain adequate organ perfusion in the 
face of normal filling pressures. It comprises both forward failure (i.e., impaired cardiac output) and backward 
failure (i.e., venous congestion). The latter is an established mechanism driving disease progression1–3.
Venous congestion is caused by overfilling of the central venous capacitance veins4 as a result of the failing 
heart with unrestrained sodium and water retention and neurohumoral activation, which may ultimately lead 
to organ injury and failure when severe and long-standing. Different target organs such as the heart, kidneys, 
liver, intestines and lungs are potentially implied. Pulmonary congestion mainly develops in case of increased 
left ventricular filling pressures, whereas abdominal congestion is a classic sign of right-sided heart failure5. It 
has been shown that both central venous pressure (CVP) and intra-abdominal pressure, as measures for venous 
congestion, are associated with kidney dysfunction in heart failure1,6–9 as well as in other settings10–12.
It remains unclear how isolated venous congestion, separate from cardiac dysfunction, leads to heart and 
kidney failure in patients13,14. However, this can be studied in a rat model with selectively increased abdominal 
1BIOMED – Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, 
Belgium. 2Doctoral school for Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium. 3Department 
of Cardiology, Ziekenhuis Oost-limburg, Genk, Belgium. 4Department of Nephrology, Jessa Ziekenhuis, Hasselt, 
Belgium. 5Clinical laboratory, Ziekenhuis Oost-Limburg, Genk, Belgium. 6Department of Pathology, Jessa 
Ziekenhuis, Hasselt, Belgium. 7Department of Pathology, Universitair Ziekenhuis Antwerpen, University of Antwerp, 
Edegem, Belgium. 8REVAL – Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, 
Diepenbeek, Belgium. 9Heart Centre Hasselt, Jessa Hospital, Hasselt, Belgium. Correspondence and requests for 
materials should be addressed to J.C. (email: jirka.cops@uhasselt.be)
Received: 26 June 2018
Accepted: 16 November 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIENtIFIC RePoRtS |         (2018) 8:17757  | DOI:10.1038/s41598-018-36189-3
venous pressure, which can be accomplished by permanently constricting the thoracic inferior vena cava (IVC)15. 
It has already been shown that such a model did not compromise cardiac preload or contractile function, while 
important alterations in kidney morphology and function were observed after twelve weeks15. However, hepatic 
function may also be affected by abdominal venous congestion. Accordingly, this study has been prolonged to an 
observational period of twenty-one weeks in which cardiac, renal and by extension hepatic function and mor-
phology are examined. Furthermore, mechanisms responsible for organ dysfunction, are investigated in depth.
Therefore, the objective of this study is to identify the deleterious effects of abdominal venous congestion on 
hepatic, renal and cardiac morphology and function as well as to investigate the underlying structural alterations 
that might explain these effects. The unique advantage of our rat model is that the effects of backward failure on 
congestion-related diseases can be investigated separately from forward failure.
Results
Surgical constriction of the IVC induces abdominal venous congestion. Baseline pre-surgical 
physical, blood, urinary and echocardiographic parameters were not statistically different between IVCc and 
SHAM rats, except for a significantly lower body weight and urine volume (p = 0.04) and a significantly higher 
heart rate (p = 0.01) in IVCc versus sham-operated rats (Tables 1–2).
At 21 weeks after surgery, jugular venous pressure was not statistically different between both groups (0.4 
[−0.8;1.9] mmHg in the SHAM group versus 0.6 [−1.0;1.8] mmHg in the IVCc group, p = 0.74 (median [25th;75th 
percentile]); Fig. 1A). Contrarily, abdominal venous pressure increased significantly in IVCc compared to SHAM 
rats (11.2 [8.5;14.1] mmHg versus 2.5 [1.7;4.0] mmHg, respectively; p < 0.0001; Fig. 1B). Physical parameters of 
IVCc versus sham-operated rats of both cohorts are shown in Table 3. After 21 weeks of abdominal venous con-
gestion, liver weight/tibia length ratio and spleen weight/tibia length ratio were significantly greater in the IVCc 
group (Table 3, p < 0.05), heart weight/tibia length ratio was significantly smaller in the IVCc group (Table 3, 
p < 0.01) and no significant differences in body weight (Table 1), body weight gain and kidney weight/tibia length 
ratio were observed between groups (Table 3). Plasma CRP levels were significantly higher in IVCc-rats (p < 0.05, 
Table 1).
Abdominal venous congestion increases the glomerular surface area and width of Bowman’s 
space without major impact on the glomerular filtration rate. Glomerular surface area and width 
of Bowman’s space were significantly greater in the IVCc versus SHAM group (p < 0.01 and p < 0.05, respectively; 
Fig. 2A–C,E). Twenty-one weeks after surgery, only the increase in glomerular surface area correlated significantly 
with the abdominal venous pressure (r = 0.55, p < 0.01; Fig. 2D). No correlation between the increase in width 
of Bowman’s space and the abdominal venous pressure was observed (r = 0.23, p = 0.30; Fig. 2F). Glomerular 
density and renal collagen deposition did not differ between both groups (Fig. 2G,H). With a similar water intake 
in both groups, 24 h urine volume was also comparable among IVCc versus sham-operated rats. Glomerular 
filtration rate, estimated by the renal creatinine clearance, did not differ between groups 21 weeks after sur-
gery. However, plasma creatinine was significantly greater in the IVC-constricted versus sham-operated group 
Baseline (week 0) Week 21
SHAM IVCc p-value SHAM IVCc p-value
Body weight (g) 252 [180;257] 175 [161;234]* 0.04 690 [621;725] 641 [579;698] 0.22
Plasma creatinine (mg/dl)# 0.18 [0.15;0.23] 0.14 [0.10;0.21] 0.20 0.26 [0.23;0.27] 0.29 [0.28;0.42]** 0.001
Plasma cystatin C (mg/dl)# 2.19 [1.12:2.49] 1.58 [1.33;2.13] 0.76 1.60 [0.95;1.85] 2.10 [1.60;2.25] 0.26
Urinary albumin (mg/g crea)# 94.9 [72.4;171.5] 113.9 [82.5;197.6] 0.49 129.8 [56.5;247.0] 87.8 [65.9;195.1] 0.74
Urinary KIM-1 (ng/g crea) 1991 [1538;2886] 2149 [1524;2684] 0.65 544 [449;639] 588 [390;680] 0.82
Urinary creatinine excretion (mg/24 h)# 51.40 [36.85;58.78] 55.80 [48.10;65.50] 0.36 51.40 [36.85;58.78] 55.80 [48.10;65.50] 0.39
Creatinine clearance (ml/min/kg) 5.91 [3.90;6.45] 5.75 [4.01;7.65] 0.70 8.40 [5.93;9.62] 8.61 [5.91;9.36] 0.77
Plasma urea (mg/dl)# 25 [18;30] 22 [19;25] 0.41 29 [27;33] 33 [29;37] 0.16
Urinary urea excretion (mg/24 h) 4259 [2553;5085] 4474 [2570;5340] 0.39 4942 [3845;6536] 5349 [3783;7669] 0.58
Urea clearance (ml/min/kg)# 2.898 [2.470;3.373] 3.236 [2.425;3.902] 0.63 0.007 [0.004;0.008] 0.006 [0.003;0.007] 0.95
Water intake (ml/24 h)# 30 [30;35] 25 [23;30] 0.11 38 [30;51] 40 [30;45] 0.73
Urine volume (ml/24 h) 6 [5;11] 5 [4;6]* 0.04 19 [16;24] 17 [14;22] 0.62
Plasma bilirubin (mg/dl) 0.03 [0.02;0.04] 0.04 [0.03;0.05] 0.07 0.04 [0.03;0.05] 0.07 [0.06;0.08]**** <0.0001
Plasma CRP (mg/dl)# 0.02 [0.0;0.04] 0.23 [0.08;0.34]* 0.019
Plasma aldosterone (ng/l) 175.9 [137.7;298.7] 262.2 [136.3;322.4] 0.48
Table 1. Baseline blood and urinary parameters and after twenty-one weeks of follow-up. Data are shown as 
median [25th percentile;75th percentile] in sham-operated (SHAM, n = 12) and IVC-constricted rats (IVCc, 
n = 11). Baseline plasma CRP and aldosterone levels are not available due to a too small sample volume. 
Data were analyzed using an unpaired t-test when parametrically distributed according to the Shapiro-Wilk 
normality test. # denotes non-parametrically distributed data, which were analyzed using a Mann-Whitney 
test. * denotes p < 0.05, ** denotes p < 0.01, **** denotes p < 0.0001. The observed statistical power of inter-
group comparisons is 0.42 and 0.59 for baseline body weight and urine volume respectively and 0.70, 0.99 and 
0.58 for plasma creatinine, bilirubin and CRP after 21 weeks, respectively. KIM-1 = kidney injury molecule 1, 
CRP = C-reactive protein, IVC = inferior vena cava, IVCc = IVC-constricted rats.
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(p < 0.01), while plasma cystatin C and urea and urinary KIM-1, albumin, creatinine excretion, urea excretion 
and urea clearance did not differ between both groups (Table 1). Plasma aldosterone (Table 1) and protein expres-
sion levels of renal angiotensin II type I receptor (ATIIT1R, Fig. 3A,B) and NAPDH oxidase 2 (NOX2, Fig. 3C,D) 
did not differ between both groups.
IVC-constricted rats develop hepatic fibrosis. IVCc rats demonstrated significantly increased plasma 
bilirubin levels after 21 weeks (p < 0.0001, Table 1). Histological examination revealed that fibrosis was markedly 
augmented in the liver of IVCc rats (p < 0.0001; Fig. 4A–C). Furthermore, collagen deposition correlated signif-
icantly with the abdominal venous pressure (r = 0.83, p < 0.0001; Fig. 4D). As indicated by immunostaining, an 
increased number of α-SMA-positive myofibroblasts was observed in IVCc versus sham-operated rats (repre-
sentative pictures: Fig. 4E,F). Fig. 4G is a representative example of a western blot for α-SMA and GAPDH from 
liver samples. As shown in Fig. 4H, protein expression levels of α-SMA were significantly increased in IVCc rats, 
21 weeks after surgery (p < 0.001).
Cardiac function remains unaltered. Echocardiographic parameters (Table 2), cardiac hemodynamic 
parameters (Table 3) and cardiac collagen deposition (Supplemental Fig. S1) were not statistically different 
between both groups after 21 weeks of surgery, except for a significantly increased posterior wall thickness in 
IVC-constricted rats (p < 0.05).
Baseline (week 0) Week 21
SHAM IVCc p-value SHAM IVCc p-value
LVEDD (mm) 5.3 [4.9;5.8] 5.0 [4.8;5.1] 0.18 7.8 [7.4;8.4] 7.7 [6.7;8.0] 0.33
LVESD (mm) 2.7 [2.3;3.1] 2.9 [2.5;3.2] 0.29 4.3 [3.8;4.7] 3.9 [3.0;4.4] 0.14
PWT (mm) 0.97 [0.82;1.02] 0.85 [0.74;0.94] 0.16 0.78 [0.72;0.86] 0.92 [0.83;1.01]* 0.04
AWT (mm)# 0.76 [0.63;0.87] 0.66 [0.57;0.66] 0.05 0.73 [0.70;0.94] 0.80 [0.70;0.92] 0.63
HR (bpm)# 398 [388;430] 441 [416;455]** 0.006 338 [318;356] 346 [334;356] 0.22
EDV (µl) 148 [124;177] 135 [105;148] 0.26 471 [404;577] 403 [323;482] 0.31
ESV (µl) # 8 [6;13] 11 [8;13] 0.42 32 [22;40] 19 [15;33] 0.13
CO (ml/min)# 56 [46;64] 55 [46;61] 0.62 158 [125;179] 132 [105;157] 0.22
Table 2. Baseline conventional echocardiography parameters and after twenty-one weeks of follow-up. Data 
are shown as median [25th percentile;75th percentile] in sham-operated (SHAM, n = 12) and IVC-constricted 
rats (IVCc, n = 11). Data were analyzed using an unpaired t-test when parametrically distributed according 
to the Shapiro-Wilk normality test. # denotes non-parametrically distributed data, which were analyzed using 
a Mann-Whitney test. * denotes p < 0.05, ** denotes p < 0.01. The observed statistical power of inter-group 
comparisons is 0.83 for baseline HR and 0.59 for PWT after 21 weeks. LVEDD = left ventricular end-diastolic 
diameter, LVESD = left-ventricular end-systolic diameter, PWT = posterior wall thickness, AWT = anterior 
wall thickness, HR = heart rate, EDV = end diastolic volume, ESV = end systolic volume, CO = cardiac output, 
IVC = inferior vena cava, IVCc = IVC-constricted rats.
Figure 1. Permanent inferior vena cava constriction is sufficient to increase the abdominal venous pressure. (A) 
jugular venous pressure above the constriction level and (B) abdominal venous pressure below the constriction 
level of sham-operated (SHAM, n = 12) and IVC-constricted rats (IVCc, n = 11). Data were analyzed using a 
Mann-Whitney test (A) or an unpaired t-test (B), according to the Shapiro-Wilk normality test. Data are shown 
as median, 25th percentile, 75th percentile, minimum and maximum. **** denotes p < 0.0001. The observed 
statistical power of inter-group comparisons is 1 in (B). IVC = inferior vena cava, IVCc = IVC-constricted rats.
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Discussion
This study explored the effects of isolated abdominal venous congestion on heart, kidneys and liver morphology 
and function. This may offer insight into how backward failure affects liver and kidney function, independent of 
cardiac failure. Our main observations are: (1) surgical constriction of the thoracic IVC succeeds to increase the 
abdominal venous pressure significantly, associated with a systemic inflammatory status; (2) abdominal con-
gestion is associated with increased glomerular surface area and Bowman’s width, suggesting the presence of 
glomerular hypertension; but (3) no significant change in glomerular filtration rate is observed; (4) abdominal 
venous congestion is associated with hepatic fibrosis and (5) cardiac function is not compromised by selective 
abdominal venous congestion.
Thoracic IVC constriction is efficient to increase the abdominal venous pressure without com-
promising cardiac preload. A rat model has been developed with increased abdominal venous pressure but 
without major impact on cardiac output or systemic hemodynamics. In this model, the thoracic IVC is narrowed 
through a surgically placed ligature15. The average abdominal venous pressure in this model typically rises to 
8–18 mmHg, which is sustained over time. In patients, an increased central venous pressure is defined as values 
of >8 mmHg1. In our model of abdominal hypertension, all abdominal organs are exposed to increased venous 
pressure and thus abdominal instead of local venous congestion is induced. The constriction is permanent and 
the model is suitable for both acute and chronic follow-ups. Importantly, this study confirmed that conventional 
echocardiographic parameters and cardiac hemodynamics were largely unaffected after surgery, thereby exclud-
ing the effects of forward failure (i. e., decreased cardiac output)in our rat model16. This gives the unique possibil-
ity to study the pathophysiology of selective backward failure, in contrast to the model of Fujimoto et al.17. In this 
previous study, right-sided heart failure was induced in rats by pulmonary artery banding and after four weeks of 
follow-up, hepatic function was investigated. The novelty of this study is emphasized by the fact that in the cur-
rent model right-sided cardiac function and cardiac preload were not compromised and both cardiac, renal and 
hepatic function were examined in depth after twenty-one weeks of follow-up.
Moreover, abdominal venous congestion induces a systemic inflammation, as evidenced by the significantly 
increased plasma CRP levels in IVCc rats. Inflammation is an important connector in the cardiorenal syndrome18 
and recently, it was shown in patients that peripheral congestion causes release of inflammatory mediators19. In 
the current rat model, inflammation could be an important contributor to the observed worsening in kidney and 
liver function, as described in the next sections.
Abdominal venous congestion alters renal morphology. In IVC-constricted rats, it was demon-
strated that adverse alterations occur in the kidneys, since both the width of Bowman’s space and the glomerular 
surface area were significantly increased after 21 weeks, similar to the 12-week follow-up study in a previous study 
by Cops et al.15. and as reported by Dong et al.20. Glomerular surface area correlated significantly with abdominal 
venous pressure, suggesting a causal relationship. In our observations, glomerular density was comparable in both 
SHAM and IVCc rats. As already explained in the study of Cops et al., these results fit with “retrogradely trans-
duced glomerular hypertension without major impact on the glomerular filtration rate (GFR)15. Theoretically, 
renal congestion leads to tubular compression and an augmented luminal pressure and in this way the trans-
glomerular pressure gradient and GFR are lowered3,8,21. in an attempt to increase the single nephron GFR, affer-
ent vasodilation and efferent vasoconstriction might have been initiated22, resulting in enlarged glomeruli and 
intraglomerular hypertension”15. Hypothetically, hyperfiltration may develop as a response to intraglomerular 
Week 21 SHAM IVCc p-value
Body weight gain (g/weeks) 461 [430;489] 462 [403;502] 0.88
Liver weight/tibia length (mg/mm) 431.8 [400.1;469.6] 498.4 [456.4;522.0]* 0.03
Spleen weight/tibia length (mg/mm)# 19.4 [16.4;22.4] 25.2 [19.1;26.5]* 0.04
Heart weight/tibia length (mg/mm) 43.8 [40.9;47.0] 35.5 [33.7;41.5]** 0.007
Kidney weight/tibia length (mg/mm)# 86.9 [83.3;95.9] 80.1 [72.7;88.1] 0.21
LVP (mmHg)# 105.3 [92.2;110.2] 101.9 [93.4;106.2] 0.58
LVEDP (mmHg) 16.9 [80;21.8] 13.7 [10.6;20.1] 0.91
dP/dtmax (mmHg/s) 2049 [1860;2591] [2027;3300] 0.20
dP/dtmin (mmHg/s) −1786 [−1991;−1485] −2096 [−2929;−1489] 0.20
Tau (s)# 0.016 [0.007;0.112] 0.010 [0.009;0.380] 0.59
Table 3. Physical and cardiac hemodynamic parameters after twenty-one week of follow-up. Data are shown 
as median [25th percentile;75th percentile] in sham-operated (SHAM, n = 12) and IVC-constricted rats (IVCc, 
n = 11). Data were analyzed using an unpaired t-test when parametrically distributed according to the Shapiro-
Wilk normality test. # denotes non-parametrically distributed data, which were analyzed using a Mann-Whitney 
test. * denotes p < 0.05, ** denotes p < 0.01. The observed statistical power of inter-group comparisons is 
0.60, 0.55 and 0.83 for liver weight/tibia length ratio, spleen/weight tibia length ratio and heart weight/tibia 
length ratio, respectively. LVP = left ventricular pressure, LVEDP = left ventricular end-diastolic pressure, dP/
dtmax = maximum value of the first derivate of LV pressure, dP/dtmin = minimum value of the first derivate of LV 
pressure, tau = time constant of LV pressure decay during the isovolumic relaxation period, IVC = inferior vena 
cava, IVCc = IVC-constricted rats.
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Figure 2. Abdominal venous congestion alters kidney morphology. Representative Masson trichrome 
staining in transverse sections of a kidney of (A) a sham-operated and (B) an IVC-constricted rat, twenty-one 
weeks after surgery. Magnification is 20×, scale bar is 100 µm. (C) Glomerular surface area, (D) glomerular 
surface area expressed as a function of abdominal venous pressure, (E) width of Bowman’s space, (F) width 
of Bowman’s space expressed as a function of abdominal venous pressure, (G) glomerular density and (H) 
quantification of renal collagen of sham-operated (SHAM, n = 12) and IVC-constricted rats (IVCc, n = 11). 
Data were analyzed using an unpaired t-test (C,G) or a Mann-Whitney test (E,H) and relations were examined 
by Pearson (D) or Spearman correlations (F), according to the Shapiro-Wilk normality test. Data are shown as 
median, 25th percentile, 75th percentile, minimum and maximum. * denotes p < 0.05, ** denotes p < 0.01. The 
observed statistical power of inter-group comparisons is 0.94 in (C) and 0.70 in (E). IVC = inferior vena cava, 
IVCc = IVC-constricted rats.
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hypertension thereby mediating progressive kidney damage, as already demonstrated in various disease set-
tings23. In addition, plasma and urinary urea excretion and urea clearance were unchanged in IVCc rats, suggest-
ing a preserved renal blood flow. However, these mechanisms are maybe too simplistic and alterations in lymph 
flow and intrarenal hemodynamic changes may also play an important role in this aspect24.
It was found that IVCc rats demonstrated increased plasma creatinine levels twenty-one weeks after sur-
gery. In heart failure patients, an elevated central venous pressure provokes renal congestion8 and consequently 
renal dysfunction, since blood flow through the kidneys is reduced more by an increase in venous pressure than 
by an equivalent decrease in arterial pressure25. The discrepancy between the rise in plasma creatinine and the 
unchanged levels of cystatin C might be explained by a higher creatinine production or less tubular secretion 
of creatinine. The 24 h creatinine excretion found in the urine collections of IVCc rats was not different from 
SHAM rats. Calculated renal creatinine clearance did not differ significantly between both experimental groups, 
due to large variations in individual urinary creatinine excretion levels. Next to an upregulated inflammatory 
status, activation of the RAAS system and oxidative stress are suggested to be important cardiorenal connectors26. 
However, no evidence of RAAS hyperactivation was observed since plasma aldosterone and protein expression 
levels of ATIIT1R did not differ between both groups. Protein expression levels of NOX2, a membrane complex 
responsible for reactive oxygen species production, also did not differ between both groups, suggesting a pre-
served redox balance. In our model, glomerular density as well as cardiac function were preserved. This implies 
renal glomerular adaptation masking relevant effects of the abdominal venous congestion on creatinine clearance 
after 21 weeks. In our previous study15, we demonstrated significantly increased plasma cystatin C levels and uri-
nary albumin levels in IVCc rats, however significance of both parameters disappeared in the current study. This 
implies a possible adaptation mechanism of the kidney whereby the kidney is able to cope provisionally with the 
renal venous congestion thanks to the aforementioned glomerulomegaly.
In this study, there was no evidence of increased renal fibrosis or tubular damage, indicating isolated hemo-
dynamically mediated alterations of function. The lack of pronounced renal implications may be explained by 
the fact that nephrons are adapting to the increased renal interstitial pressure and have not been destroyed yet 
Figure 3. Abdominal venous congestion does not lead to renal RAAS system hyperactivation or oxidative 
stress. (A) Representative western blot for renal angiotensin II type I receptor (ATIIT1R) and β-actin of 
sham-operated (SHAM, n = 12) and IVC-constricted rats (IVCc, n = 11), twenty-one weeks after surgery. (B) 
Quantitative analysis of renal ATIIT1R protein expression normalized to β-actin of SHAM and IVCc rats. (C) 
Representative western blot for renal NAPDH oxidase 2 (NOX2) and β-actin of SHAM and IVCc rats. (D) 
Quantitative analysis of renal NOX2 protein expression normalized to β-actin of SHAM and IVCc rats. Samples 
for western blot for ATTIIT1R and NOX2 were derived from the same animal experiment. However, samples 
were dived over two gels, due to lack of space, and blots were processed in parallel. Solid line = IVC-constricted 
rats, dotted line = sham-operated rats. Data were analyzed using a Mann-Whitney test (B,D). Data are shown 
as median, 25th percentile, 75th percentile, minimum and maximum. IVC = inferior vena cava, IVCc = IVC-
constricted rats, ATIIT1R = angiotensin II type I receptor, NOX2 = NAPDH oxidase 2.
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Figure 4. Abdominal venous congestion leads to hepatic fibrosis and increases hepatic α-SMA expression. 
Representative Masson trichrome staining in hepatic transverse sections of (A) a sham-operated (SHAM) and 
(B) an IVC-constricted rat (IVCC), twenty-one weeks after surgery. Magnification is 20×, scale bar is 100 µm. 
(C) Quantification of hepatic collagen and (D) total collagen expressed as a function of abdominal venous 
pressure of SHAM (n = 12) and IVCc rats (n = 11). Representative α-SMA immunohistochemical staining in 
hepatic transverse sections of (E) a SHAM rat and (F) an IVCc rat. Magnification is 20×, scale bar is 100 µm. 
(G) Representative western blot for hepatic α-SMA and GAPDH of SHAM and IVCc rats. Samples were derived 
from the same animal experiment. However, samples were dived over two gels, due to lack of space, and blots 
were processed in parallel. Solid line = IVC-constricted rats, dotted line = sham-operated rats. (H) Quantitative 
analysis of hepatic α-SMA protein expression normalized to GAPDH of SHAM and IVCc rats. Data were 
analyzed using an unpaired t-test (C) or a Mann-Whitney test (H), according to the Shapiro-Wilk normality 
test. Relations were examined by Pearson correlations (D). Data are shown as median, 25th percentile, 75th 
percentile, minimum and maximum. *** denotes p < 0.001, **** denotesp < 0.0001. The observed statistical 
power of inter-group comparisons is 0.99 in (C) and 0.91 in (H). IVC = inferior vena cava, IVCc = IVC-
constricted rats, α-SMA = alpha-smooth muscle actin.
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or by the fact that the increased abdominal venous pressure possibly did not reach a value sufficient to increase 
intrarenal pressure, thereby causing renal hypoperfusion and tubular damage. Moreover, abdominal venous con-
gestion was induced in an otherwise healthy rat, in contrast to patients which already have developed heart and/
or kidney failure before displaying signs and symptoms of congestion, and it is notoriously difficult to develop a 
rodent model of albuminuria or renal failure. To summarize, kidney function seems to adapt after 21 weeks of 
abdominal venous congestion. However, by prolonging the observational period, renal glomerular and tubular 
damage and fibrosis may occur and the already raised plasma creatinine levels could represent the initial sign of 
renal deterioration.
Abdominal venous congestion induces hepatic fibrosis. Hepatic dysfunction is a frequent compli-
cation of right-sided heart failure in patients since an elevated CVP causes passive hepatic congestion, which 
is referred to as congestive hepatopathy17,27, resulting in increased levels of bilirubin28. We reported a signifi-
cantly greater plasma bilirubin level, liver weight/tibia length weight ratio and spleen weight/tibia length ratio in 
IVC-constricted rats after 21 weeks of follow-up, indicating clinically meaningful hepatic congestion resulting 
from the constriction, probably due to the fact that the liver is the first organ affected by the increased abdominal 
venous pressure. This may have clinical implications, as an elevated serum bilirubin is a risk factor for prema-
ture death in patients with pulmonary arterial hypertension and right-sided heart failure29. An increased spleen 
weight/tibia length ratio is defined in literature as an indicator of portal hypertension and reflects splanchnic 
system involvement16,30. Due to abdominal venous congestion and portal hypertension, hepatic hydrostatic pres-
sure increases and results in edema and hemorrhage, thereby compromising oxygenation and eventually induc-
ing hepatocellular necrosis17,27. The pathological appearance of a liver affected by venous congestion is speckled 
and known as a ‘nutmeg liver’31, which was also observed in this study, suggesting development of congestive 
hepatopathy17,27.
The Masson trichrome staining indicated a marked increase in hepatic collagen deposition with a peripor-
tal to centrilobular distribution pattern and development of fibrous septa. When liver damage is persistent and 
progressive, hepatic regeneration is halted and hepatic fibrosis develops. In time, progressive fibrosis results 
in cirrhosis. Congestion induces hepatocellular necrosis and results in increased transforming growth factor 
β (TGF-β) production by Kupffer cells, which activates hepatic stellate cells (HSCs)32. Activated HSCs trans-
form to α-SMA-positive myofibroblasts, responsible for collagen I and III synthesis and thus promoting hepatic 
fibrosis17,33. Activation of HSCs is observed in this study based on a significantly greater hepatic α-SMA protein 
expression in IVCc rats after 21 weeks. In addition, the increase in α-SMA protein expression correlates signifi-
cantly with the abdominal venous pressure. The augmented abdominal venous pressure leads to hepatic sinusoi-
dal congestion which clinically contributes to development of fibrosis in congestive hepatopathy, possibly through 
the mechanism of sinusoidal thrombosis, according to Simonetto et al.16. but contradicted by Fujimoto et al.17. 
The increased collagen deposition creates a physical impairment to the bidirectional flow of plasma between the 
hepatic sinusoidal lumen and hepatocytes, ultimately altering hepatic function and liver congestion34.
In acute decompensated heart failure (ADHF) patients, an increased venous pressure is reflected by an aug-
mented liver stiffness, ultimately also contributing to hepatic fibrosis. In non-alcoholic fatty liver disease patients, 
the fibrosis-4 index is known as a marker of liver stiffness35. Recently, it was demonstrated in heart failure patients 
that the fibrosis-4 index was associated with hyaluronic acid, type IV collagen 7S, right and left heart volume 
overload, brain natriuretic peptide (BNP) and higher all-cause mortality36. Hence, an increased FIB4 index is also 
a marker of liver stiffness in ADHF patients and is indicative of hepatic fibrosis due to underlying congestion36. 
Besides an increased liver stiffness, abdominal venous congestion causes remodeling of the extracellular matrix 
(ECM), during which collagen fragments are deposited into the general circulation. 7S domain of collagen type 
IV (P4NP 7S), expressed in the basement membrane of the hepatic ECM, is such a released fragment and has 
been shown to be a marker of hepatic fibrogenesis37. In heart failure patients, P4NP 7S correlated with BNP, 
right-sided cardiac pressure, pulmonary capillary wedge pressure and gamma-glutamyltransferase, indicating an 
accelerated production of hepatic collagen type IV and ECM remodeling. Since cardiac index was not correlated 
with P4NP 7S, it was concluded that the accelerated turnover should be attributed to presence of congestion. 
Third, right ventricular dysfunction and concomitant systemic congestion can also result from pulmonary hyper-
tension. Yoshihisa et al. demonstrated that serum P4NP 7S correlated with right-sided volume overload and an 
increased central venous pressure and that PHNP 7S was associated with higher mortality in pulmonary hyper-
tension patients38. Since increased P4NP 7S levels reflect ECM remodeling resulting from congestion-induced 
organ injury, this particular collagen fragment can be applied to investigate hepatic fibrosis37,38.
Based on the aforementioned arguments, the importance of backward failure caused by right-sided heart 
failure or hepatic congestion in the pathophysiology of congestive hepatopathy, is highlighted. To summarize, 
abdominal venous congestion leads in the current rat model to hepatic deterioration over time. In the same 
model, kidney function adapts after 21 weeks, suggesting that the liver is more susceptible or vulnerable to 
abdominal congestion. The clinical implications for patients are that after normalization of an increased abdom-
inal venous pressure, kidney function and morphology is restored, in contrast to a chronically altered liver func-
tion and morphology.
Limitations. This study had a maximal follow-up of 21 weeks, so only conclusions on the short to 
middle-term effects of abdominal venous congestion can be deferred. In the future, the model may be investigated 
for a longer period of time to investigate if renal glomerular and tubular damage and fibrosis occurs. Second, 
renal blood flow was not assessed. Third, GFR was only assessed by creatinine clearance and evaluation by inulin 
clearance is lacking. Fourth, markers reflecting sympathetic nervous activity should be provided, since this is 
an important cardiorenal connector. Fifth, assessment of cardiac function was focused on the left-sided heart. 
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However, parameters of right-sided cardiac function may also deviate as a result of the constriction and should be 
investigated in the future. Finally, a comprehensive assessment of liver function is lacking.
Conclusion
This study demonstrated that abdominal venous congestion induces glomerulomegaly, suggesting retrogradely 
transduced glomerular hypertension with hyperfiltration and without major impact on the glomerular filtration 
rate. In addition, liver fibrosis was observed in this model. The observed kidney and liver dysfunction may be 
attributed to an upregulated inflammatory status. Importantly, cardiac function remained comparable between 
both groups, excluding forward failure as the reason for the observations. Thus a rat model is now available to 
study the influence of abdominal venous congestion per se in congestion-related diseases, independent of cardiac 
output or underlying kidney function.
Material and Methods
Animals and housing. This study conforms to the EU Directive 2010/63/EU for animal experiments and 
was approved by the Ethical Committee for Animal Experiments of Hasselt University, Belgium (protocol num-
ber: 201553A1). Rats had ad libitum access to food and water and were maintained in a temperature (22 °C) and 
light (12:12 h cycle) controlled animal facility15.
Study design. Forty rats (male Sprague-Dawley, 135 ± 15 g, Charles River, France) were divided into 2 
groups: twelve sham-operated rats (SHAM group) were compared to eleven rats subjected to inferior vena cava 
(IVC) constriction (IVCc group) and both groups were studied for 21 weeks. The perioperative mortality rate in 
the IVCc group was 61% (17/28) compared to 0% in the SHAM group (0/12). Abdominal venous congestion was 
induced by increasing the abdominal venous pressure through surgical constriction of the thoracic IVC15.
Experimental protocol. Surgical constriction of the IVC was applied as described before by Cops et al.15. 
Briefly, rats were intubated and anesthetized (1.5% isoflurane volume supplemented with oxygen) and a right 
anterolateral thoracotomy was performed. The thoracic IVC was visualized to apply a permanent constric-
tion by tying a surgical wire (6–0 prolene, VMD, Belgium) around the IVC and a 20 gauge (0.812 mm) needle. 
Afterwards, the 20 G needle was removed and the wound was closed. The same surgical procedure was applied in 
sham-operated rats except for application of the constriction. Meloxicam (1 mg/kg, Boehringer, Germany) was 
administered subcutaneously pre-operatively and was continued postoperatively twice a day for three consecutive 
days, while antibiotics (10 mg/kg/day, Baytril, Bayer, Belgium) were administered for 5 consecutive days postop-
eratively via the drinking water. At 21 weeks after surgery, rats were weighed, 24 h urine samples were collected 
using standard rodent metabolic cages (Technilab-BMI, the Netherlands), blood samples were obtained from the 
tail artery and echocardiography was performed, both under isoflurane anesthesia (1.5–2% volume supplemented 
with oxygen). After performing invasive hemodynamic measurements, rats were sacrificed with an overdose of 
pentobarbital (200 mg/kg, i.p.). and heart, kidneys and liver were excised for histological and molecular examina-
tion. Before embedding in paraffin, tissue sections were fixed overnight in 4% paraformaldehyde and conserved 
in 70% ethanol. Residual tissues were crushed to a fine powder, snap frozen in liquid nitrogen and stored at 
−80 °C15.
Blood and urine biochemical analysis. As described in Cops et al., blood samples were centrifuged (2000 
rpm, 10 min) and plasma was preserved (−20 °C) for later analysis. Plasma samples were analyzed for biliru-
bin, creatinine, urea, cystatin C, aldosterone and C-reactive protein (CRP) using an automated analyzer (Cobas 
8000 ISE module and Cobas 8000 c702 and c502 module, Roche Diagnostics, Germany)15,39–41. Urine samples 
were centrifuged (1500 rpm, 5 min) and preserved (−20 °C) for later analysis. Urine samples were analyzed for 
creatinine, urea and albumin using an automated analyzer (Cobas 8000 ISE module and Cobas 8000 c702 and 
c502 module, Roche Diagnostics, Germany). Urinary kidney injury molecule 1 (KIM-1) concentrations were 
determined using the rat TIM-1/KIM-1/HAVCR DuoSet ELISA kit (DY3689, R&D Systems, USA) according to 
the manufacturer’s instructions and all measurements were performed in duplicate15. Creatinine clearance (ml/
min/kg) was calculated as follows = [(urinary creatinine (mg/dl) × urinary volume (ml/24 h))/(plasma creatinine 
(mg/dl) × 1440 min) * 1000]/body weight15,42. Likewise, urea clearance was calculated.
Echocardiography measurements. Left ventricular function was the primary outcome to assess cardiac 
function in response to the constriction. Left ventricular echocardiography was performed at baseline and 21 
weeks after surgery using the GE VIVID i ultrasound machine and a 10S transducer (GE Vingmed Ultrasound, 
version 7.0.1, Norway), under isoflurane anesthesia in spontaneously breathing rats (1.5–2% volume supple-
mented with oxygen), as described previously15. In B-mode at a temporal resolution of ≈200 frames per second, 
a standard parasternal long-axis image and a short-axis image at midventricular level were acquired. The fol-
lowing parameters were obtained from the parasternal short-axis view: left ventricular end-diastolic diameter 
(LVEDD), LV end-systolic diameter (LVESD), posterior and anterior wall thicknesses (PWT, AWT). Left ven-
tricular end-diastolic volumes (EDV) and LV end-systolic volumes (ESV) were calculated by π * DM2 * B/6. DM 
indicates the systolic/diastolic diameter of the ventricle on midventricular short-axis view and B is the LV length 
on the parasternal long-axis image. Heart rate (HR) was determined by defining end systole and end diastole as 
the minimum and maximum LV short-axis area, respectively. Stroke volume (SV) was calculated as EDV – ESV. 
Cardiac output (CO) was calculated as SV * HR (EchoPAC workstation, GE Vingmed Ultrasound, version 7.0.1, 
Norway)15.
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Venous and arterial hemodynamic measurements. At the end of the experimental period of 21 weeks, 
rats were subjected to invasive venous and arterial hemodynamic measurements. After induction of anesthe-
sia (1.5–2% isoflurane volume supplemented by oxygen), a calibrated 2F micro tip high-fidelity pressure cath-
eter (Millar Instruments, AD Instruments, Germany), was inserted into the right jugular vein to obtain jugular 
venous pressure. Next, the left femoral vein was cannulated and the catheter was advanced into the abdominal 
IVC to obtain abdominal venous pressure. Third, LV pressure (LVP) and left ventricular end-diastolic pressure 
(LVED) were recorded by inserting the catheter in the right carotid artery and advancing the catheter into the left 
ventricle. The peak time derivatives (dP/dtmax and dP/dtmin) and the time constant of LV pressure decay during 
the isovolumic relaxation period (tau) were calculated using LabChart v7.3.7 software (Millar Instruments, AD 
Instruments, Germany). Afterwards, rats were sacrificed with an overdose of pentobarbital (200 mg/kg, i.p.)15.
Fibrosis measurement. Five µm thickness sections of liver, kidney and heart tissue, subjected to the Masson 
trichrome staining method, were scanned using the Mirax Desk (Carl Zeiss MicroImaging, Germany). Fibrosis 
was assessed at 20X magnification in four randomly chosen sections in each organ per rat, by outlining the area 
of collagen deposition and excluding blood vessels, as described previously15,43. Quantification of percentage 
collagen was performed by calculating the ratio of the area of collagen deposition to the global area using an 
automated image analysis program (AxioVision 4.6, Carl Zeiss MicroImaging, Germany)15.
Kidney morphology. Kidney morphology was assessed in kidney sections subjected to the Masson tri-
chrome staining method, as described previously15. Glomerular surface area was measured in 10 randomly cho-
sen glomeruli per rat and width of Bowman’s space was measured 5 times per Bowman’s space in 10 randomly 
chosen glomeruli per rat. Glomerular density was calculated by counting well-preserved glomeruli in 5 randomly 
selected fields with a surface area of 3.14 mm² in renal sections of each rat using an analysis program (Pannoramic 
Viewer, 3DHISTECH, Hungary)15,44–46.
Western blot. Protein concentrations of liver and kidney samples were determined using the BCA protein 
assay kit (Thermo Fisher, Belgium). Samples containing the same amount of proteins were separated on a 12% 
SDS-page gel with a mini protean 3 electrophoresis system (Bio-rad Laboratories, Belgium), then transferred to 
a polyvinylidene fluoride (PVDF) membrane and blocked two hours with 5% milk in Tris-buffered solution con-
taining 0.1% Tween-20 (TBS-T) or 5% bovine serum albumin (BSA) in TBS-T, depending on the primary anti-
body. The membrane was incubated overnight at 4 °C in the presence of an alpha-smooth muscle actin antibody 
(α-SMA, 1/2000, ab5694, Abcam, UK), anti-angiotensin II type I receptor antibody (ATIIT1R, 1/2000, ab18801, 
Abcam, UK) or NAPDH oxidase 2 antibody (NOX2, 1/2000, ab31092, Abcam, UK). Secondary swine anti-rabbit 
horseradish peroxidase-conjugated antibody (P0217, DAKO, Belgium) at a dilution of 1/2500 was used. Both 
primary and secondary antibodies for α-SMA and NOX2 were diluted in 5% milk-TBS-T, while primary and 
secondary antibodies for ATIIT1R were diluted in 5% BSA-TBS-T. α-SMA, ATIIT1R and NOX2 were visualized 
using the chemiluminescence (ECL) technique using the Pierce ECL Plus Western Blotting Substrate Kit (Thermo 
Fisher, Belgium) and quantified using Image Quant TL software v8.1 (GE Healthcare Europe, Belgium). Data 
were normalized to GAPDH protein levels (1/2000, MA5–15738-HRP, Thermo Fisher, Belgium) or to β-actin 
protein levels (1/2500, sc-4778, Santa Cruz, USA). The original full-length western blots of ATIIT1R, NOX2 and 
α-SMA are shown in Supplementary Figs 2–4.
Immunohistochemistry. Five-µm-thick hepatic tissue sections were deparaffinized in xylene and rehy-
drated serially with alcohol and water, followed by microwave antigen retrieval for 20 min at 98 °C in 10 mM 
sodium citrate buffer (0.05% tween 20, pH 6.0). Endogenous peroxidase was blocked with fresh 0.3% hydro-
gen peroxide in phosphate buffered saline (PBS) for ten minutes at room temperature. Sections were blocked 
2 h with protein block (DAKO, Belgium) in PBS containing 0.5% triton and were incubated overnight at 4 °C 
in the presence of a specific alpha-smooth muscle actin antibody (α-SMA, 1/200, ab5694, Abcam, UK). After 
being washed three times in PBS, sections were incubated with biotinylated secondary swine anti-rabbit antibody 
(E0431, DAKO, Belgium) for 1 h and with streptavidine-HRP (1/800, P0397, DAKO, Belgium) for 30 min. α-SMA 
was visualized using DAB (K3468, DAKO, Belgium) and sections were counterstained with hematoxylin. Sections 
were observed at 20X magnification Mirax Desk and Mirax viewer, Carl Zeiss MicroImaging, Germany).
Statistical analysis. Data are expressed as median [25th percentile; 75th percentile]. Normality was tested 
using the Shapiro-Wilk normality test. Data were analyzed using an unpaired t-test or a Mann-Whitney test as 
appropriate. Relations were examined by Pearson’s r or Spearman’s ρ as appropriate. A 2-tailed value of p < 0.05 
was considered statistically significant15. Statistical analysis was performed using GraphPad Prism (GraphPad 
Prism Software 7.04, USA). The observed statistical power of inter-group comparisons was calculated by use of 
G*Power 3.1.9.2 (Universität Düsseldorf, Germany). An observed power ≥0.80 was considered sufficient.
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